Navigation Links
Mouse Model Beneficial to Study of Head and Neck Cancer

he researchers were able to induce invasive HNSCC with 100 percent incidence.

‘Head and neck lesions developed from this mouse model have many molecular alterations similar to those found in HNSCC patients. Additionally, we have identified several new biomarkers that data suggest may be good targets for HNSCC therapy,’ Wang said.

Wang was recruited to OHSU to study head and neck cancers. Through her research and through personal acquaintances, her passion was stirred to help people with this type of disfiguring cancer.

‘Before I came to OHSU, a woman who was helping me here with my new house asked what was bringing me to Portland.

When I told her it was to lead OHSU's research on head and neck cancer, she said, 'Oh, my god, we were meant to meet. My husband was just diagnosed with head and neck cancer.' During my interactions with her after we moved to Portland, I realized how much this disease impacts patients and their family members. Then, only a few months later, a family friend was diagnosed with head and neck cancer. These two cases made me realize that this terrible disease could happen to people all around us, even our loved ones, and inspired me to my best effort in leading this study,’ Wang said.

‘It was a true team effort of the head and neck cancer research division, especially with Dr. Shilong Lu, the first author on this study, who made the major contribution to this model,’ Wang said. Shilong LU, M.D., Ph.D., is research assistant professor of otolaryngology/head and neck surgery in the OHSU School of Medicine.

Peter Andersen, M.D., F.A.C.S., associate professor of otolaryngology/head and neck surgery in the OHSU School of Medicine; and Christopher L. Corless, M.D., professor of pathology in the OHSU School of Medicine, and member of the OHSU Cancer Institute, are co-authors on this study.

Source: Eurealert
'"/>




Page: 1 2

Related medicine news :

1. Mouse Allergen Found In Homes Could Trigger Asthma In Kids
2. Researchers Develop Mouse Model Of Brain Tumor
3. German Scientists Create Stem Cells From Mouse Testes
4. Mouse Models To Determine The Cause Of Aggressive Leukemia
5. Scientists Discover New RNAs in Mouse Testicles
6. Scientists Isolate Leukemia Stem Cells in Mouse Model
7. Mouse Model Demonstrates Immune System Reaction In Chlamydia Infection
8. Mouse Gene With Gene Stutter Will Help Leukemia Research
9. Rett Syndrome Reversed in Genetic Mouse Model
10. Treatment Extends Survival in Mouse Model of Spinal Muscular Atrophy
11. Mouse Study Suggests Anxiety Disorders Take Root in Infancy
Post Your Comments:
(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2
...ies, those called up to risk their lives in the se...d even ill-treated. Apparently the US is no except... their grievances during a hearing of the Presiden...l at Washington on Saturday. Speaking from exper...
...euticals Incorporated, a global biotechnology comp...rial on new hepatitis C drug, telaprevir. The drug...t has been shown. The planned interim results of ...nnounced at Barcelona on Saturday at the 42nd Annu...
...ted pessimism hangs thickly over Britain’s junior ...th since UK’s young doctors took the street in pro...te of most of them having dished out thousands of ... that would make them eligible for NHS employment....
...ts at Bonn University have created a software syst...l implants significantly. //With the aid of the so... exactly those signals, which are expected and can...two dozens of patients in Germany and the U.S. hav...
Other Medicine News:Health News:Military Healthcare Lacks Compassion, Say US Soldiers 2Health News:New Hepatitis C Drug Shows Promise 2Health News:UK’s Junior Doctors Losing Hop 2Health News:Software System to Improve the Function of Retinal Implants 2Health News:Software System to Improve the Function of Retinal Implants 3
(Date:9/4/2008)...e/ -- Axentis Pharma AG has,initiated a clinical p...ty,of a new therapeutic formulation for the treatm...is patients. The new formulation allows an,establi... the site of,infection. The forthcoming trial will...f the new drug. Initial results are expected in su...
(Date:9/3/2008)...re-FirstCall/ --,Pharmaceutical company Pharmaxis ...as enrolled the first subject into its second pivo...n cystic fibrosis sufferers., The Phase 3 trial i...rica, Argentina and Germany, and is the final clin...t Bronchitol for cystic fibrosis in the,United Sta...
(Date:9/3/2008)...se Awareness Month, CHARLOTTESVILLE, Va., Sept. 3...clinical-stage drug-development company commercial... needs, announced today that it has begun,to enrol...ead drug,candidate trans sodium crocetinate (TSC)....trials.gov Website, is investigating TSC as a trea...
(Date:9/3/2008)...aunch Progress and Adlea R...all Today at 11:30 am ET, SOUTH SAN FRANCISCO, Ca...nc. (Nasdaq: ANSV ) announced today that the comp...cial and late-stage product development to,acceler...ain management,company. The company also provided ...
Breaking Medicine Technology:Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 2Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 2Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 3Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 4Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company 5Novel Angiogenic Drugs Including a Future Blockbuster from Genzyme Could Revolutionize Treatment of Peripheral Arterial Disease 492 1Novel Angiogenic Drugs Including a Future Blockbuster from Genzyme Could Revolutionize Treatment of Peripheral Arterial Disease 492 2Study Shows Plasma Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery 241 1Study Shows Plasma Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery 241 2Study Shows Plasma Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery 241 3RAND researchers offer options to improve immigrant health care quality access 963 1RAND researchers offer options to improve immigrant health care quality access 963 2Was ability to run early mans Achilles heel 3F 338 1Was ability to run early mans Achilles heel 3F 338 2Was ability to run early mans Achilles heel 3F 338 3
...GUEL, Calif.--(BUSINESS WIRE)--Apr 26, 2007 - Aeol...day the publication*,in the April 18, 2007 issue o...rs at the University of Colorado and National Jewi...the Company,s first,orally available catalytic ant... in an animal model of Parkinson,s disease ("PD")....
...le="MARGIN: 0in 0in 0pt; TEXT-ALIGN: left; tab-sto...0in 0pt; tab-stops: list .5in; mso-list: l1 level1...Y: ,News Gothic MT,; mso-bidi-font-weight: bold">,...enefits of adding,Diovan to conventional therapy ...s: list .5in; mso-list: l1 level1 lfo2">, <span st...
Other Medicine Technology:Study Demonstrating Aeolus Compound's Neuroprotection in,Parkinson's Disease Published in the Journal of Neuroscience 2Study Demonstrating Aeolus Compound's Neuroprotection in,Parkinson's Disease Published in the Journal of Neuroscience 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 4Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 5Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 6Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 7Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 8Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 9Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 10Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 11Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 12
The MediLive ImageBox is the first, easy-to-use digital,recording device that integrates with the surgical microscope and video camera., ,It simplifies image capturing by burning the still imag
With MediLive MindStream you can make, cut and edit digital videos, add commentaries and notes, and save them. MediLive MindStream - intuitive user interface and high-resolution monitor all in one.
The VISUCAM non-mydriatic fundus camera increases the quality and simplicity of fundus imaging. Compact, yet big enough to set the standard in ophthalmic photography, it features a unique combination
...er Monitoring System, equipped with the latest Epi...is algorithm, Heart Rate Variability analysis and ...ith an Epicardia System in place have complete con...t their needs, and managing their data. The Epicar...
Medicine Products: